In order to amplify its impact in the biomedical field and to meet the actual challenges in R&D, the Fund has decided to redirect its support towards the development in Belgium of an ecosystem of high-level researchers to help accelerating the development of innovative research projects.
With the Baillet Latour Biomedical Award, the Baillet Latour Fund wishes to offer major support to basic, clinical or translational biomedical research in Belgium.
The Fund also wishes to strengthen the status and visibility of promising young researchers in Belgium and to support their development towards eminent independent research leaders in their field.
It additionally seeks to facilitate their grant applications to Belgian and European funding sources for their innovative research and intends to contribute to retaining promising new talents and to attract foreign ones.
The Baillet Latour Biomedical Award will be awarded to independent investigators of any nationality in the early phase of their career to conduct basic, translational or clinical biomedical research in Belgium and consolidate their independent research team or program.
The Award amounts to 1,000,000 € over 5 years to support a research project in one of the five biomedical domains selected by the Baillet Latour Fund. The topic of the 2024 Award is "Cancer".
A first instalment of 400.000 € will be credited to the Host Institution at the start of the funding period. A second instalment of 200.000 € will be credited at the beginning of year 3. The third and fourth instalment of 200.000 € each, to be made available at the beginning of years 4 and 5, will be subject to the positive evaluation of a mid-term report and a site visit.
- Eligible expenses:
Eligible expenses encompass personnel costs (excluding the salary of the PI), running costs and equipment. Overheads costs are not eligible.